In the development of AD, elevated hyperphosphorylated tau and its deposition are a better indication of disease progression and has a stronger relationship with a decline in cognition than Aβ42 or Aβ40 (Nelson et al., 2012; Aschenbrenner et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.